Defiance ETFs, LLC

Mutual Fund

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1732541 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$245,674

-$28,613 QoQ

Shares Held

394

+11.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#991

of 1,322 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Defiance ETFs, LLC holds $776,633 across 3 Biotechnology names. REGN ranks #2 (31.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,000	$496,730
2	REGN	Regeneron Pharmaceuticals, Inc. This page	394	$245,674
3	AVXL	Anavex Life Sciences Corp.	13,216	$34,229

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$245,674	394	+11.0%	Shares	Sole	2026-08-14
2026-03-31	$274,287	355	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.